Vergoeding 2017-2021 voor ATC-subgroep J06BB : Specifieke immunoglobulinen
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| J06BB02 Tetanusimmunoglobuline (Tetagam ®) | 5.822 | 6.699 | 47.926 | 296.220 | 239.500 |
| J06BB03 Varicella-zoster-immunoglobuline (Varizig ®) | 32.565 | 68.073 | 345.760 | 130.590 | 180.150 |
| J06BB04 Hepatitis b-immunoglobuline (Zutectra ®) | 356.270 | 344.830 | 448.850 | 439.570 | 422.100 |
| J06BB16 Palivizumab (Synagis ®) | 12.785.800 | 11.702.600 | 9.783.000 | 9.114.300 | 9.147.800 |
| Totaal | 13.180.457 | 12.122.202 | 10.625.536 | 9.980.680 | 9.989.550 |